Papers/PMID:24114400
The Auckland calcium study: 5-year post-trial follow-up.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2014The record
2 findings · 1 compound · 2 endpoints · 1 null
What it reported
How to read these marksWhat moved
1 finding
Ca(2+) — decreases vertebral fracture incidence
Evidence strength: very limited.Findingreplicated ×1“Over the 10-year period, there was no effect on total fracture (HR 0.90, 95% CI 0.75-1.07) or hip fracture incidence (1.40, 0.89-2.21), but significant reductions in forearm (0.62, 0.43-0.89) and vertebral fractures (0.52, 0.32-0.85) in those assigned to calcium.”
Quoted verbatim from The Auckland calcium study: 5-year post-trial follow-up.. - Study
- RCT
- Dose
- 1 g/day calcium citrate for 5 years
- Population
- Postmenopausal women in the Auckland calcium study, 10 years from randomisation (5 years of supplement, 5 years post-trial follow-up)
Effect 0.52 hazard ratio, 95% CI 0.32 to 0.85
The Auckland calcium study: 5-year post-trial follow-up.2014PMID:2411440010.1007/s00198-013-2526-zPermalink
What did not
1 finding
Ca(2+) — no detected effect on hip fracture incidence
Evidence strength: very limited.FindingNull resultreplicated ×3“Over the 10-year period, there was no effect on total fracture (HR 0.90, 95% CI 0.75-1.07) or hip fracture incidence (1.40, 0.89-2.21), but significant reductions in forearm (0.62, 0.43-0.89) and vertebral fractures (0.52, 0.32-0.85) in those assigned to calcium.”
Quoted verbatim from The Auckland calcium study: 5-year post-trial follow-up.. - Study
- RCT
- Dose
- 1 g/day calcium citrate for 5 years
- Population
- Postmenopausal women in the Auckland calcium study, 10 years from randomisation (5 years of supplement, 5 years post-trial follow-up)
Effect 1.4 hazard ratio, 95% CI 0.89 to 2.21
The Auckland calcium study: 5-year post-trial follow-up.2014PMID:2411440010.1007/s00198-013-2526-zPermalink